The largest database of trusted experimental protocols

Purexpress transcription translation coupled system

Manufactured by New England Biolabs
Sourced in United States

The PURExpress transcription-translation coupled system is a cell-free protein synthesis kit that allows for the in vitro expression of proteins. The system uses purified components from Escherichia coli to facilitate the coupled transcription and translation of user-supplied DNA templates.

Automatically generated - may contain errors

3 protocols using purexpress transcription translation coupled system

1

Ribosome Stalling Analysis with Drug Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The synthetic DNA templates encoding the amino acid sequences for Rst1, Rst2, ErmBL and YrbA open reading frames (ORFs) were generated by polymerase chain reaction (PCR) and AccuPrime Taq DNA Polymerase (Thermo Fisher Scientific, USA). The sequences of the primers used for PCR are shown in Supplementary Table S1. The toe-printing analysis of drug-dependent ribosome stalling analysis (Figure 1D, E; Figure S1) was carried out using Rst1, Rst2, ErmBL and YrbA mRNA templates as previously described (15 (link),16 (link)) with minor modifications. Toe-printing reactions were carried out in 5-μl aliquots containing a PURExpress transcription-translation coupled system (New England Biolabs, USA) to which the test template was added (17 (link)). The reactions were incubated at 37°C for 20–25 min. Reverse transcription on the templates was carried out using radioactively labeled primer NV1 (Supplementary Table S1). Primer extension products were resolved on 6% sequencing gels as described previously (18 (link)). The final concentrations of drugs were: 50 μM THR, 50 μM apidaecin (API), 50 μM retapamulin (RET), and 50 μM erythromycin (ERY).
+ Open protocol
+ Expand
2

Toe-printing Analysis of Drug-dependent Ribosome Stalling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The toe-printing analysis of drug-dependent ribosome stalling was carried out using synthetic ermDL DNA template as previously described55 (link)–57 (link) with minor modifications. Toe-printing reactions were carried out in 5-µl aliquots containing PURExpress transcription-translation coupled system (New England Biolabs, USA) to which the DNA template was added58 (link). The reactions were incubated at 37 °C for 20–25 min. Reverse transcription on the templates was carried out using radioactively labeled primer NV1 (5’-GGTTATAATGAATTTTGCTTATTAAC-3’). Primer extension products were resolved on 6% denaturing sequencing gels. The final concentrations of drugs were: 100 µM HygA and 50 µM ERY. In all reactions, we used 50 µM mupirocin (inhibitor of isoleucyl-tRNA-synthetase) to arrest ribosomes at the Ile codon downstream of the macrolide arrest site (Supplementary Fig. 1).
+ Open protocol
+ Expand
3

Profiling Drug-Dependent Translation Stalling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The synthetic DNA template encoding the amino acid sequence MLILTRRVGETLMIGDEVTVTV (SI Appendix, Table S2) was initially generated by polymerase chain reaction (PCR) using E. coli BW25113 genomic DNA and AccuPrime Taq DNA Polymerase (Thermo Fisher Scientific). The sequences of the primers used for PCR are shown in SI Appendix, Table S3.
The toe-printing assay for drug-dependent translation stalling was performed as previously described in ref. 30 (link) with minor changes. Toe-printing reactions were carried out in 5-µL aliquots containing PURExpress transcription-translation coupled system (New England Biolabs) with 0.5 picomoles of the DNA template added (27 (link)). The reactions were incubated at 37 °C for 15 min. Reverse transcription on the templates was carried out using radioactively labeled primer NV1 (SI Appendix, Table S3). Primer extension products were resolved on 6% sequencing gels as described previously (31 (link)). The final concentrations of SAR varied for different experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!